Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy Participants
Clinical trial NCT02812251 · COMPLETED
Trial details
- NCT number
- NCT02812251
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-07
- Primary completion
- 2016-11-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.